IAIM
TMO icon

International Assets Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

International Assets Investment Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.79M Sell
5,443
-232
-4% -$111K 0.17% 114
2026
Q1 		$2.81M Sell
5,675
-246
-4% -$134K 0.19% 95
2025
Q4 		$3.43M Buy
5,921
+3,743
+172% +$2.12M 0.23% 78
2025
Q3 		$918K Buy
2,178
+10
+0.5% +$4.66K 0.07% 261
2025
Q2 		$879K Sell
2,168
-7
-0.3% -$2.93K 0.07% 272
2025
Q1 		$1.08M Buy
2,175
+334
+18% +$181K 0.09% 216
2024
Q4 		$962K Sell
1,841
-1,414,575
-100% -$778M 0.08% 234
2024
Q3 		$13.3K Buy
1,416,416
+1,414,556
+76,051% +$837M 0.04% 366
2024
Q2 		$1.03M Sell
1,860
-104
-5% -$59.6K 0.1% 194
2024
Q1 		$1.13M Buy
1,964
+62
+3% +$34.8K 0.12% 184
2023
Q4 		$1.01M Buy
1,902
+276
+17% +$134K 0.13% 176
2023
Q3 		$810K Buy
1,626
+493
+44% +$263K 0.11% 173
2023
Q2 		$591K Buy
1,133
+22
+2% +$11.9K 0.08% 240
2023
Q1 		$640K Sell
1,111
-102,365
-99% -$57.7M 0.09% 219
2022
Q4 		$901K Buy
103,476
+102,615
+11,918% +$54.4M 0.09% 213
2022
Q3 		$437K Sell
861
-10
-1% -$5.6K 0.09% 222
2022
Q2 		$473 Sell
871
-16
-2% -$8.81K 0.04% 218
2022
Q1 		$524K Sell
887
-87
-9% -$50K 0.09% 220
2021
Q4 		$650K Buy
974
+77
+9% +$48.1K 0.11% 201
2021
Q3 		$512K Buy
897
+81
+10% +$44.5K 0.09% 237
2021
Q2 		$412K Sell
816
-2,902
-78% -$1.37M 0.08% 265
2021
Q1 		$795K Buy
3,718
+788
+27% +$376K 0.07% 255
2020
Q4 		$435K Buy
2,930
+1,808
+161% +$848K 0.08% 232
2020
Q3 		$495K Sell
1,122
-413
-27% -$171K 0.12% 165
2020
Q2 		$556K Buy
1,535
+753
+96% +$252K 0.13% 150
2020
Q1 		$222K Buy
+782
New +$247K 0.07% 254

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

International Assets Investment Management's TMO Position: Q2 2026 in Review

International Assets Investment Management reduced its Thermo Fisher Scientific (TMO) stake by 4.1% in Q2 2026, selling an estimated $111K and leaving 5,443 shares worth $2.79M. The position accounts for 0.17% of the portfolio, ranked #114.

International Assets Investment Management first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.43M in Q4 2025. 1,244 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • International Assets Investment Management held 5,443 shares of Thermo Fisher Scientific worth $2.79M as of Q2 2026.
  • International Assets Investment Management sold 232 Thermo Fisher Scientific shares in Q2 2026, an estimated $111K.
  • Thermo Fisher Scientific made up 0.17% of International Assets Investment Management's portfolio in Q2 2026, its #114 holding.
  • International Assets Investment Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • International Assets Investment Management's Thermo Fisher Scientific position peaked at $3.43M in Q4 2025.
  • 1,244 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.